longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cronos

CRON

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 17.95, within the reasonable range, cheaper than 44.44% of the time in the past 1 years, and the industry ranks 31/256, the industry Median -1.38.

17.95xP/E
$3.41Stock price
$0.19Earnings per share
17.95xP/E
Stock price$3.41Earnings per share$0.19

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
17.32x
Typical range
-561.17x–28.43x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb
14.06x62.25%$130.49B
GSKUSGSK
15.71x14.52%$101.27B
UCBJYUSUCB S.A.
18.14x--$46.20B
HLNUSHaleon
18.61x1.74%$40.39B
OTSKYUSOtsuka Pharmaceutical
14.43x--$37.36B
DSNKYUSDaiichi Sankyo
19.67x--$33.04B
ZTSUSZoetis
11.19x6.81%$29.52B
ALPMYUSAstellas Pharma
11.50x--$26.81B
JAZZUSJazz Pharma
16.44x349.11%$15.47B
OPHLYUSOno Pharmaceutical
15.37x--$7.49B
INDVUSIndivior Pharmaceuticals
12.23x126.83%$4.35B
OGNUSOrganon
17.25x211.11%$3.61B
SNPHYUSSanten Pharmaceutical
14.16x--$3.50B
HRMYUSHarmony Biosciences
12.85x45.48%$2.33B
PBHUSPrestige Brands
12.93x7.48%$2.22B
GTBIFUSGreen Thumb Industries Inc.
14.46x--$1.83B
ANIPUSANI Pharma
16.88x51.20%$1.68B
PAHCUSPhibro Animal Health
14.54x26.75%$1.45B
OMERUSOmeros
11.27x1,913.34%$1.41B
CRONUSCronos
17.95x889.34%$1.26B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.